Tessa Jowell BRAIN MATRIX - Platform Study (BRAIN MATRIX)
A British Feasibility Study of Molecular Stratification and Targeted Therapy to Optimize the Clinical Management of Patients With Glioma by Enhancing Clinical Outcomes, Reducing Avoidable Toxicity, Improving Management of Post-operative Residual & Recurrent Disease and Improving Survivorship
Sponsor: Genomics England
This observational or N/A phase trial investigates Glioma and is currently actively recruiting participants. Genomics England leads this study, which shows 18 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
18 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Jan 2025 — Feb 2026 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Dec 2022 — Dec 2023 [monthly]
Recruiting
-
Jul 2022 — Dec 2022 [monthly]
Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Recruiting
-
Feb 2022 — Jun 2022 [monthly]
Recruiting
-
Dec 2021 — Feb 2022 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
-
Sep 2021 — Nov 2021 [monthly]
Recruiting
-
Feb 2021 — Sep 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Not Yet Recruiting
-
Apr 2020 — Jul 2020 [monthly]
Not Yet Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Genomics England
- The Brain Tumour Charity
- University of Birmingham
- University of Edinburgh
- University of Oxford
For direct contact, visit the study record on ClinicalTrials.gov .